Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;126(10):1345-1355.
doi: 10.1007/s11547-021-01376-2. Epub 2021 Jun 28.

Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters

Francesco Mungai  1 , Giovanni Battista Verrone  2 , Luigi Bonasera  2 , Eleonora Bicci  2 , Michele Pietragalla  3 , Cosimo Nardi  3 , Valentina Berti  3 , Lorenzo Nicola Mazzoni  4 , Vittorio Miele  2
Affiliations

Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters

Francesco Mungai et al. Radiol Med. 2021 Oct.

Abstract

Background and purpose: Morphologic magnetic resonance imaging (MRI) for characterization of salivary gland tumors has limited utility, and the use of perfusion MRI data in the clinical setting is controversial. We examined the potential of tissue-normalized dynamic contrast-enhanced (DCE) MRI pharmacokinetic parameters of salivary gland tumors as imaging biomarkers for characterization and differentiation between benign and malignant lesions.

Materials and methods: DCE-MR images acquired from 60 patients with parotid and submandibular gland tumors were retrospectively reviewed. Pharmacokinetic parameters as transfer constant (Ktrans), rate constant (Kep), extracellular space volume (Ve), fractional plasma volume (Vp), and AEC (area of all times enhancement curve) were measured on both the lesion and the normal contralateral salivary gland parenchyma. Lesion/parenchyma ratio (L/P) for each parameter was calculated.

Results: Five groups of lesions were identified (reference: histopathology): pleomorphic adenomas(n = 20), Warthin tumors(n = 16), other benign entities(n = 4), non-Hodgkin lymphomas(n = 4), and malignancies(n = 16). Significant differences were seen for mean values of L/PKtrans (higher in malignancies), L/PKep (lower in adenomas than Warthin tumors), L/PVe (lower in Warthin tumors and lymphomas), L/PVp (higher in Warthin tumors and malignancies than adenomas), and L/PAEC (higher in malignancies). Significant differences were found between benign and malignant (non-lymphoproliferative) lesions in mean value of L/PKtrans (0.485 and 1.581), L/PVp (1.288 and 2.834), and L/PAEC (0.682 and 1.910). ROC analysis demonstrated the highest AUC (0.96) for L/PAEC, with sensitivity and specificity for malignancy of 93.8% and 97.5% (cutoff value = 1.038).

Conclusion: Lesion/parenchyma ratio of DCE-MRI pharmacokinetic data could be helpful for recognizing the principal types of salivary gland tumors; L/PAEC seems a valuable biomarker for differentiating benign from malignant tumors.

Keywords: Dynamic contrast-enhanced MRI; Imaging biomarkers; Lesion/parenchyma ratio; Pharmacokinetic analysis; Salivary gland tumors.

PubMed Disclaimer

References

    1. Sood S, McGurk M, Vaz F (2016) Management of salivary gland tumours: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 130:S142–S149. https://doi.org/10.1017/s0022215116000566 - DOI - PubMed - PMC
    1. Abdel Razek AAK, Mukherji SK (2018) State-of-the-art imaging of salivary gland tumors. Neuroimaging Clin N Am 28:303–317. https://doi.org/10.1016/j.nic.2018.01.009 - DOI - PubMed
    1. Dai YL, King AD (2018) State of the art MRI in head and neck cancer. Clin Radiol 73:45–59. https://doi.org/10.1016/j.crad.2017.05.020 - DOI - PubMed
    1. Prasad RS (2016) Parotid gland imaging. Otolaryngol Clin North Am 49:285–312. https://doi.org/10.1016/j.otc.2015.10.003 - DOI - PubMed
    1. Abdel Razek AAK, Mukherji SK (2018) Imaging of minor salivary glands. Neuroimaging Clin N Am 28:295–302. https://doi.org/10.1016/j.nic.2018.01.008 - DOI - PubMed

LinkOut - more resources